Clinical trial • Phase I • Immunology

Clinical trial in Crohn's disease|Psoriasis

Phase I trial for Crohn's disease|Psoriasis. 56 participants.

Overview

Trial Therapeutic Area
Immunology
Trial Disease
Crohn's disease|Psoriasis
Trial Stage
Phase I
Drug Modality
Diagnostic agent

Key dates

Initial CTIS Submission Date
22-07-2024
First CTIS Authorization Date
24-10-2024

Trial design

Phase I trial across 1 site in Netherlands.

Target Sample Size
56

Eligibility

Recruits 56 No vulnerable population selected in the trial record; assent/consent procedures not specified..

Vulnerable Population
No vulnerable population selected in the trial record; assent/consent procedures not specified.

Recruitment

Planned Sample Size
56
Recruitment Window Months
18

Geography

Total Number Of Sites
1
Total Number Of Participants
56

Netherlands

Earliest CTIS Part Ii Submission Date
21-10-2024
Latest Decision Or Authorization Date
01-09-2025
Processing Time Days
315
Number Of Sites
1
Number Of Participants
56

Sites

Site Name
Universitair Medisch Centrum Groningen
Department Name
Gastroenterology
Principal Investigator Name
Wouter Nagengast
Principal Investigator Email
w.b.nagengast@umcg.nl
Contact Person Name
Wouter Nagengast
Contact Person Email
w.b.nagengast@umcg.nl
Number Of Participants
56

Sponsor

Primary sponsor

Full Name
University Medical Center Groningen
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
Netherlands

Related trials

Other published trials that may interest you.